Clinical Trials Arena on MSN1d
BioMarin’s trial for phenylketonuria therapy meets primary efficacy endpointBioMarin Pharmaceutical has reported that the multi-centre Phase III PEGASUS trial of Palynziq (pegvaliase-pqpz) has met its ...
Just getting protein in your day isn't enough, experts say. It's also important to make sure you're getting complete protein, ...
Detailed study results will be presented at an upcoming medical meeting and submitted to health authorities later this year to expand Palynziq’s label to include adolescents.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback